Insiders Ardelyx, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
7.77 ^USD	-3.60%		-10.89%	+25.32%

09/05	Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing	MT
09/05	Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing	MT

Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing	10/05	MT
Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing	10/05	MT
Ardelyx Insider Sold Shares Worth $333,574, According to a Recent SEC Filing	08/05	MT
Ardelyx, Inc. Announces the Appointment of Mike Kelliher as Executive Vice President, Corporate Development and Strategy	25/03	CI
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing	23/03	MT
Ardelyx Insider Sold Shares Worth $253,925, According to a Recent SEC Filing	14/12	MT
Ardelyx Insider Sold Shares Worth $105,476, According to a Recent SEC Filing	09/12	MT
Ardelyx Announces Departure of Geoffrey Block as Board Member	14/11	CI
Insider Buy: Ardelyx	18/22/18	MT
Fulcrum Therapeutics Appoints Santiago Arroyo as Chief Medical Officer, Jeff Jacobs as Chief Scientific Officer	08/22/08	MT
Insider Sell: Ardelyx	08/22/08	MT
Ardelyx, Inc. Announces Executive Changes	15/22/15	CI
Ardelyx, Inc. Announces Board Changes	15/21/15	CI
Insider Trends: Insider Purchase Eases Back 90-Day Trend of Sales at Ardelyx	11/20/11	MT
Ardelyx, Inc. Announces Executive Changes	10/20/10	CI
Ardelyx, Inc. Appoints Justin Renz as Chief Financial Officer	09/20/09	CI
Ardelyx, Inc. Announces Appointment of Susan Rodriguez as First Chief Commercial Officer	19/20/19	CI
Ardelyx, Inc Announces Management and Board Changes	16/20/16	CI
Ardelyx, Inc. Announces Resignation of Mark Kaufmann as Chief Financial Officer	27/19/27	CI
Ardelyx, Inc. Announces Board Changes	19/19/19	CI

No results for this search